2m 2m 2m 2m 2m 2m 2m
Virax Biolabs (VRAX)
NASDAQ
$4.09+$0.02 (+0.49%)
Price as of Jul 14, 2026 6:50 AM EDT- $417.1MMarket Cap
- -82.42%1-Year Change
- BiotechnologyIndustry
Virax Biolabs (VRAX)
$4.09+$0.02 (+0.49%)
Earnings Score
Valuation | VRAX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | N/A | ||
Growth | N/A | ||
Low Earnings Volatility | N/A |
Momentum Score
Valuation | VRAX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 18.00% | ||
12-Month Momentum | -80.33% | ||
3-Month Risk Adjusted Momentum | 16.65% | ||
12-Month Risk Adjusted Momentum | -52.27% |
True Yield
Valuation | VRAX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
No data found